232 related articles for article (PubMed ID: 23271153)
1. Nursing guidelines for administration of immunoglobulin replacement therapy.
Younger ME; Aro L; Blouin W; Duff C; Epland KB; Murphy E; Sedlak D;
J Infus Nurs; 2013; 36(1):58-68. PubMed ID: 23271153
[TBL] [Abstract][Full Text] [Related]
2. The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline.
Shehata N; Palda V; Bowen T; Haddad E; Issekutz TB; Mazer B; Schellenberg R; Warrington R; Easton D; Anderson D; Hume H
Transfus Med Rev; 2010 Jan; 24 Suppl 1():S28-50. PubMed ID: 19962579
[TBL] [Abstract][Full Text] [Related]
3. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
McCormack PL
BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447
[TBL] [Abstract][Full Text] [Related]
4. Developing practice guidelines for the administration of intravenous immunoglobulin.
Murphy E; Martin S; Patterson JV
J Infus Nurs; 2005; 28(4):265-72. PubMed ID: 16106210
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies.
Borte M; Kriván G; Derfalvi B; Maródi L; Harrer T; Jolles S; Bourgeois C; Engl W; Leibl H; McCoy B; Gelmont D; Yel L
Clin Exp Immunol; 2017 Jan; 187(1):146-159. PubMed ID: 27613250
[TBL] [Abstract][Full Text] [Related]
6. [Subcutaneous immunoglobulin substitution and therapy].
Gulácsy V; Maródi L
Orv Hetil; 2011 Jan; 152(2):64-7. PubMed ID: 21177233
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous immunoglobulin replacement therapy with Hizentra, the first 20% SCIG preparation: a practical approach.
Jolles S; Sleasman JW
Adv Ther; 2011 Jul; 28(7):521-33. PubMed ID: 21681653
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU
Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411
[TBL] [Abstract][Full Text] [Related]
9. Indications and safety of intravenous and subcutaneous immunoglobulin therapy.
Rezaei N; Abolhassani H; Aghamohammadi A; Ochs HD
Expert Rev Clin Immunol; 2011 May; 7(3):301-16. PubMed ID: 21595597
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of patients with primary antibody deficiencies in Germany].
Borte M; Oertelt C; Högy B
Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin replacement therapy in primary antibody deficiency diseases--maximizing success.
Durandy A; Wahn V; Petteway S; Gelfand EW
Int Arch Allergy Immunol; 2005 Mar; 136(3):217-29. PubMed ID: 15713984
[TBL] [Abstract][Full Text] [Related]
12. 7th International Immunoglobulin Conference: Immunoglobulin in clinical practice.
Shapiro RS; Borte M
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):65-6. PubMed ID: 25546766
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous Immunoglobulin in Oncology Clinical Practice.
Streu E
Clin J Oncol Nurs; 2016 Aug; 20(4):437-9. PubMed ID: 27441518
[TBL] [Abstract][Full Text] [Related]
14. IgG replacement therapy, no size fits all.
Bonilla FA
Clin Immunol; 2011 May; 139(2):107-9. PubMed ID: 21420364
[No Abstract] [Full Text] [Related]
15. Use of intravenous immunoglobulin G (IVIG).
Looney RJ; Huggins J
Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
[TBL] [Abstract][Full Text] [Related]
16. Giving intravenous immunoglobulin.
Scherf R; White-Reid K
RN; 2008 Jan; 71(1):29-34; quiz 35. PubMed ID: 18271361
[No Abstract] [Full Text] [Related]
17. The nurse's role in administration of intravenous immunoglobulin therapy.
Kirmse J
Home Healthc Nurse; 2009 Feb; 27(2):104-11; quiz 112-3. PubMed ID: 19212223
[TBL] [Abstract][Full Text] [Related]
18. Recommended indications for the administration of polyclonal immunoglobulin preparations.
Delforge M; Farber CM; Spath P; Kaveri S; Witte T; Misbah SA; Hübner R; Haerynck F; Latinne D; Muylle L; Toungouz M; Deneys V;
Acta Clin Belg; 2011; 66(5):346-60. PubMed ID: 22145269
[TBL] [Abstract][Full Text] [Related]
19. Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases.
Kobayashi RH; Litzman J; Rizvi S; Kreuwel H; Hoeller S; Gupta S
Immunotherapy; 2022 Mar; 14(4):259-270. PubMed ID: 34986666
[TBL] [Abstract][Full Text] [Related]
20. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies].
Lewandowicz-Uszyńska A; Jankowski A
Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
